Basic Information
LncRNA/CircRNA Name | CCAT1 |
Synonyms | CCAT1, CARLo-5, onco-lncRNA-40 |
Region | GRCh38_8:127207382-127219268 |
Ensemble | ENSG00000247844 |
Refseq | NR_108049 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR, Luciferase reporter assay, RIP |
Sample | Breast cancer tissues, human breast cancer cell lines (MCF-7 and MDA-MB-231) |
Expression Pattern | up-regulated |
Function Description | CCAT1 was up-regulated and miR-148b was down-regulated in radioresistant breast cancer tissues compared with radiosensitive breast cancer tissues.CCAT1 down-regulation reduced colony formation rates and caspase3 activity in breast cancer cells under irradiation. Moreover, CCAT1 could negatively regulate miR-148b expression. Furthermore, overexpression of miR-148b suppressed colony survival fraction and caspase3 expression under irradiation in breast cancer cells, which was exacerbated by CCAT1 knockdown. |
Pubmed ID | 29024383 |
Year | 2017 |
Title | Down-regulation of LncRNA CCAT1 enhances radiosensitivity via regulating miR-148b in breast cancer. |
External Links
Links for CCAT1 | GenBank HGNC NONCODE |
Links for breast cancer | OMIM COSMIC |